相关实验视频

Updated: Sep 13, 2025

Quantification of Coenzyme A in Cells and Tissues

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

在人类疾病中向托酸酶:生物化学和药物治疗

Xinnan Zhang¹, Bo Zhang¹, Xinze Li¹

¹School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.

Biochemical pharmacology

|August 3, 2025

概括

泛酸酶 (PANKs) 是辅酶A (CoA) 生产的关键,并与PKAN和帕金森病等疾病有关. 本综述详细介绍了PANK的角色,为新的治疗策略提供了洞察力.

科学领域:

生物化学生物化学
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

泛酸激酶 (PANKs) 催化了协酶A (CoA) 生物合成中的速度限制步骤.
PANK家族包括PANK1,PANK2,PANK3和PANK4,每一个都有不同的角色.
PANKs与各种人类疾病有关,包括神经退行性疾病和代谢疾病.

研究的目的:

审查过去二十年来关于PANK家族的研究进展.
阐明PANK活动的结构性质,分子机制和调节器.
为了澄清 PANKs 和人类疾病之间的关系,以治疗向.

主要方法:

关于PANK家族成员研究的文献综述.
对银行结构,功能和监管的分析.
综合证据,将PANK与疾病病原发生联系起来.

主要成果:

PANKs在泛氨酸激酶相关的神经退行 (PKAN),酸血 (PA),脂质疾病,帕金森病 (PD),质瘤,清细胞细胞癌 (ccRCC) 和胰岛素耐药性 (IR) 中发挥着关键作用.
正在积极研究将PANK与这些多种疾病联系在一起的精确机制.
PANK活性调节剂提供潜在的治疗途径.

结论:

针对PANKs,CoA生物合成的调节者,是治疗各种人类疾病的有希望的策略.
了解PANK可以弥合基础生物化学和临床药物治疗之间的差距.
对PANKs作用的进一步研究可能会导致新的疾病治疗方法.

关键词:

细胞和分子机制的机制辅酶A是一种辅酶.人类疾病人类疾病潘托酸氨酸激酶是一种泛酸氨酸激酶.潘托酸酶相关的神经退行症.信号通道的信号通道.

更多相关视频

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

相关概念视频

Protein Kinases and Phosphatases

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

ATP Synthase: Mechanism

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...